BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33152351)

  • 61. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
    Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
    BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
    Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
    Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
    Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
    Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glycoprotein 130 Inhibitor Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.
    Huang Z; Liu Z; Luo Q; Zhao Z; Zhao Q; Zheng Y; Xi Q; Tang Y
    Can J Cardiol; 2016 Nov; 32(11):1356.e1-1356.e10. PubMed ID: 27160963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Small-molecule inhibitor LF3 restrains the development of pulmonary hypertension through the Wnt/β-catenin pathway.
    Lei Y; Yang Q; Nie Y; Wan J; Deng M
    Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1277-1289. PubMed ID: 34410330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB).
    Li Y; Liu S; Zhang Y; Gao Q; Sun W; Fu L; Cao J
    Cardiovasc Pathol; 2018; 37():8-14. PubMed ID: 30172777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.
    Yang S; Banerjee S; Freitas Ad; Cui H; Xie N; Abraham E; Liu G
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L521-9. PubMed ID: 22227207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
    Revermann M; Neofitidou S; Kirschning T; Schloss M; Brandes RP; Hofstetter C
    PLoS One; 2014; 9(1):e86636. PubMed ID: 24497961
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.
    Chen X; Zhou W; Hu Q; Huang L
    Congenit Heart Dis; 2019 May; 14(3):396-402. PubMed ID: 30811836
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway.
    Zhang W; Li Y; Xi X; Zhu G; Wang S; Liu Y; Song M
    Int J Mol Med; 2020 Feb; 45(2):461-474. PubMed ID: 31894295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension.
    Ravi Y; Selvendiran K; Meduru S; Citro L; Naidu S; Khan M; Rivera BK; Sai-Sudhakar CB; Kuppusamy P
    Cell Biochem Biophys; 2013 Nov; 67(2):363-72. PubMed ID: 22205501
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
    Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
    Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
    Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
    Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
    Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.